HHS

Harte Hanks Inc

HHS, USA

Harte Hanks, Inc. operates as a customer experience company in the United States and internationally. It operates through three segments: Marketing Services, Customer Care, and Fulfillment and Logistics. It offers data and analytics, including audience identification, profiling, segmentation and prioritization, and predictive modeling and data strategy; research, an understanding of customers, category, competitors, and capabilities; strategy, which plans and executes omnichannel marketing, demand generation, and customer experience programs; creative and content, including creative concepts, messaging and content assets for print, broadcast, direct mail, website, app, display, social, mobile, search engine marketing, and voice; marketing technology, a website and app development, e-commerce development and enablement, database building and management, platform architecture creation, and marketing automation; digital and multi-channel marketing execution and advertising; demand generation and account based marketing; and managed marketing services. It also provides product, print-on-demand, and mail fulfillment services, including as printing on demand, managing product recalls, and distributing literature and promotional products; and third-party logistics and freight optimization services. In addition, the company offers inside sales outsourcing, which provides B2B enterprises, and small to midsized businesses with an outsourced sales service; lead generation services; and sales play development, as well as customer service outsourcing, customer care technology and artificial intelligence transformation, and self-service technology. It serves B2B, healthcare, pharmaceuticals, health insurance, consumer, travel, hospitality, streaming, entertainment, quick service restaurants, financial, fintech, automotive, and retail industries. The company was founded in 1923 and is headquartered in Chelmsford, Massachusetts.

https://www.hartehanks.com

Stock Price

$ 0.00

0% increase compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
HHS
stock
HHS

C3.ai (AI) Stock News Today: Mixed Rebound After Q2 2026 Earnings, HHS Deal and Conflicting Analyst Targets ts2.tech

Read more →
HHS
stock
HHS

Improved Revenues Required Before Harte Hanks, Inc. (NASDAQ:HHS) Stock's 25% Jump Looks Justified simplywall.st

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-09-30)

Rating:

STRONG BUY

Target Price:

$17.5

Analyst Picks

Strong Buy

1

Buy

0

Hold

0

Sell

0

Strong Sell

0

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Book Ratio (P/B)

-

Very Low

1.20

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very Low

-11.50 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Very Low

-2.47 %

Low ≤ 2%

High ≥ 10%

Free Cash Flow - Revenue % (FCF)

-

Very Low

6.98 %

Low ≤ 5%

High ≥ 15%

Debt to Equity

-

Very Low

3.66

Low ≥ 1

High ≤ 0.3

Investors

* Institutions hold a combined 38.80% of the total shares of Harte Hanks Inc

1.

Blair William & Co

(8.9125%)

since

2025/06/30

2.

Westerly Capital Management LLC

(8.3482%)

since

2025/06/30

3.

Vanguard Group Inc

(4.0101%)

since

2025/06/30

4.

Vanguard Total Stock Mkt Idx Inv

(2.561%)

since

2025/07/31

5.

Warburg Value B

(1.8207%)

since

2025/07/31

6.

UBS Asset Mgmt Americas Inc

(1.5847%)

since

2025/06/30

8.

Krilogy Advisors LLC

(1.5105%)

since

2025/06/30

9.

Vanguard Institutional Extnd Mkt Idx Tr

(0.9393%)

since

2025/07/31

10.

Geode Capital Management, LLC

(0.8821%)

since

2025/06/30

11.

UBS Group AG

(0.6546%)

since

2025/06/30

12.

Dimensional Fund Advisors, Inc.

(0.6202%)

since

2025/06/30

13.

Bridgeway Capital Management, LLC

(0.5509%)

since

2025/06/30

14.

Renaissance Technologies Corp

(0.5233%)

since

2025/06/30

15.

Northern Trust Corp

(0.4535%)

since

2025/06/30

16.

BlackRock Inc

(0.4473%)

since

2025/06/30

17.

Fidelity Extended Market Index

(0.4042%)

since

2025/07/31

18.

Bridgeway Ultra-Small Company Market

(0.2697%)

since

2025/06/30

19.

Raffles Associates LP

(0.2567%)

since

2025/06/30

20.

State Street Corp

(0.2535%)

since

2025/06/30

21.

Arrowstreet Capital Limited Partnership

(0.232%)

since

2025/06/30

22.

iShares Micro-Cap ETF

(0.2014%)

since

2025/08/31

23.

Goldman Sachs Group Inc

(0.176%)

since

2025/06/30

24.

LSV Asset Management

(0.1713%)

since

2025/06/30

25.

Fidelity Total Market Index

(0.1492%)

since

2025/07/31

26.

Man Group PLC

(0.149%)

since

2025/06/30

27.

Dimensional US Small Cap ETF

(0.1216%)

since

2025/08/29

28.

Bridgeway Ultra-Small Company

(0.1112%)

since

2025/06/30

29.

Spartan Extended Market Index Pool F

(0.1088%)

since

2025/07/31

30.

Extended Equity Market Fund K

(0.1043%)

since

2025/06/30

31.

Bridgeway Omni Small-Cap Value

(0.1038%)

since

2025/06/30

32.

Bridgeway Omni Small-Cap Value N

(0.1038%)

since

2025/06/30

33.

Fidelity Series Total Market Index

(0.0915%)

since

2025/07/31

34.

DFA US Small Cap I

(0.0818%)

since

2025/07/31

35.

Fidelity Nasdaq Composite Index

(0.076%)

since

2025/07/31

36.

DFA US Targeted Value I

(0.0755%)

since

2025/07/31

37.

Northern Trust Extended Eq Market Idx

(0.0669%)

since

2025/06/30

38.

NT Ext Equity Mkt Idx Fd - L

(0.0669%)

since

2025/06/30

39.

Wells Fargo & Co

(0.0169%)

since

2025/06/30

40.

Bank of America Corp

(0.0008%)

since

2025/06/30

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

2025-12-31

EPS Estimate

0.52

Latest Release

Date

2025-09-30

EPS Actual

-0.3083

EPS Estimate

0.41

EPS Difference

-0.7183

Surprise Percent

-175.1951%

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Potential Value Candidate(5.5)
Defensive
Moderately Defensive(5.5)
Dividend
Weak Dividend Profile(3)
Economic Moat
Some Competitive Advantage(5.3)
GARP
Not Attractive for GARP(2.5)
Growth
Weak Growth Prospect(2.5)
Momentum
Moderate Momentum(4.5)
Net Net
Possible Net-Net(4.5)
Quality
Moderate Quality(4.5)
Value
Fair Value(3.5)

Income Statement

(Last Updated 2025-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.